Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 546641 - 546660 out of 553687 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AC07) tocilizumab (adm: P) | TOFIDENCE 20MG/ML INJ,SOLN,20ML | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;COVID-19 virus infection;Arthritis, Juvenile Rheumatoid | OrganonLLC |
| USA | (L04AC07) tocilizumab (adm: P) | TOFIDENCE 20MG/ML INJ,SOLN,20ML | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;COVID-19 virus infection;Arthritis, Juvenile Rheumatoid | OrganonLLC |
| USA | (L04AC07) tocilizumab (adm: P) | TOFIDENCE 20MG/ML INJ,SOLN,4ML | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;COVID-19 virus infection;Arthritis, Juvenile Rheumatoid | OrganonLLC |
| USA | (L04AC07) tocilizumab (adm: P) | TOFIDENCE 20MG/ML INJ,SOLN,4ML | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;COVID-19 virus infection;Arthritis, Juvenile Rheumatoid | OrganonLLC |
| USA | (L04AC07) tocilizumab (adm: P) | TYENNE 20MG/ML INJ,SOLN | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabi,LLC |
| USA | (L04AC07) tocilizumab (adm: P) | TYENNE 20MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabi,LLC |
| USA | (L04AC07) tocilizumab (adm: P) | TYENNE 20MG/ML INJ,SOLN | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabi,LLC |
| USA | (L04AC07) tocilizumab (adm: P) | TYENNE 20MG/ML INJ,SOLN | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabi,LLC |
| USA | (L04AC07) tocilizumab (adm: P) | TYENNE 20MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabi,LLC |
| USA | (L04AC07) tocilizumab (adm: P) | TYENNE 20MG/ML INJ,SOLN | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabi,LLC |
| USA | (L04AC07) tocilizumab (adm: P) | TOCILIZUMAB-AAZG 162MG/0.9ML INJ,SOLN,SYRINGE | 0.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | FreseniusKabi,LLC |
| USA | (L04AC07) tocilizumab (adm: P) | TOCILIZUMAB-AAZG 162MG/0.9ML INJ,SOLN,SYRINGE | 0.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | FreseniusKabi,LLC |
| USA | (L04AC07) tocilizumab (adm: P) | TOCILIZUMAB-AAZG 162MG/0.9ML INJ,SOLN,SYRINGE | 0.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | FreseniusKabi,LLC |
| USA | (L04AC07) tocilizumab (adm: P) | TOCILIZUMAB-AAZG 162MG/0.9ML INJ,SOLN,SYRINGE | 0.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | FreseniusKabi,LLC |
| USA | (L04AC08) canakinumab (adm: P) | ILARIS 150MG PF LYPHL VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cryopyrin-Associated Periodic Syndromes;Arthritis, Juvenile Rheumatoid;Arthritis, Gouty | NovartisPharmaceuticalsCorporation |
| USA | (L04AC08) canakinumab (adm: P) | ILARIS 150MG PF LYPHL VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cryopyrin-Associated Periodic Syndromes;Arthritis, Juvenile Rheumatoid;Arthritis, Gouty | NovartisPharmaceuticalsCorporation |
| USA | (L04AC10) secukinumab (adm: P) | COSENTYX 25MG/ML INJ,SOLN | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisPharmaceuticalsCorporation |
| USA | (L04AC10) secukinumab (adm: P) | COSENTYX (1 SYRINGE) | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisPharmaceuticalsCorporation |
| USA | (L04AC10) secukinumab (adm: P) | COSENTYX (1 SYRINGE) | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisPharmaceuticalsCorporation |
| USA | (L04AC10) secukinumab (adm: P) | COSENTYX (2 SYRINGES) | 2X1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisPharmaceuticalsCorporation |
Pages
